Anacor Pharmaceuticals, Inc. Insider Trading for June 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Anacor Pharmaceuticals, Inc. for June 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.20 | 12,500 | 65,000 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.74 | 15,000 | 101,100 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.92 | 30,000 | 207,600 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | D | 99.25 | 33,886 | 3,363,186 | 0 | 33.9 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | D | 14.22 | 7,500 | 106,650 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | D | 17.14 | 813 | 13,935 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | D | 69.40 | 4,403 | 305,568 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Sell | D | 99.25 | 853 | 84,660 | 0 | 853 to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Sell | D | 99.25 | 89,000 | 8,833,250 | 0 | 89 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 5.20 | 15,000 | 78,000 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 6.74 | 24,000 | 161,760 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | D | 6.92 | 30,000 | 207,600 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Option Exercise | D | 14.22 | 18,000 | 255,960 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Leonard Keith R | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | D | 25.48 | 27,000 | 687,960 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 78.91 | 22,136 | 1,746,752 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 78.91 | 22,136 | 1,746,752 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 17.14 | 47,000 | 805,580 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 17.14 | 47,000 | 805,580 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 12.49 | 30,000 | 374,700 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 12.49 | 30,000 | 374,700 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 7.25 | 12,957 | 93,938 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 7.25 | 12,957 | 93,938 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.96 | 80,000 | 556,800 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.96 | 80,000 | 556,800 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.92 | 33,239 | 230,014 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 6.92 | 33,239 | 230,014 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.59 | 27,661 | 154,625 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.59 | 27,661 | 154,625 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.00 | 3,849 | 19,245 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 5.00 | 3,849 | 19,245 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 4,375 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 4,375 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | D | 99.25 | 44,194 | 4,386,255 | 0 | 44.2 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | D | 99.25 | 44,194 | 4,386,255 | 0 | 44.2 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 69.34 | 28,793 | 1,996,507 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 69.34 | 28,793 | 1,996,507 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 4,004 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 4,004 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 8,008 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 8,008 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | D | 99.25 | 10,488 | 1,040,934 | 0 | 10.5 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | D | 99.25 | 10,488 | 1,040,934 | 0 | 10.5 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 78.91 | 73,788 | 5,822,611 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 78.91 | 73,788 | 5,822,611 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 37.81 | 84,100 | 3,179,821 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 37.81 | 84,100 | 3,179,821 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 21.21 | 394,000 | 8,356,740 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 21.21 | 394,000 | 8,356,740 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 14,584 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 14,584 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 12,890 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 12,890 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | D | 99.25 | 231,311 | 22,957,617 | 0 | 231.3 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | D | 99.25 | 231,311 | 22,957,617 | 0 | 231.3 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 78.91 | 31,623 | 2,495,371 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 78.91 | 31,623 | 2,495,371 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 15.30 | 30,000 | 459,000 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 15.30 | 30,000 | 459,000 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,250 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,250 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | D | 99.25 | 30,132 | 2,990,601 | 0 | 30.1 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | D | 99.25 | 30,132 | 2,990,601 | 0 | 30.1 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 37.81 | 28,400 | 1,073,804 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 19.96 | 61,000 | 1,217,560 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Option Exercise | D | 0.00 | 6,930 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | D | 99.25 | 68,985 | 6,846,761 | 0 | 69 K to 0 (-100.00 %) |
| Jun 03 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | S | 99.28 | 751 | 74,559 | 10,255 | 11 K to 10.3 K (-6.82 %) |